NEWS ABOUT THE CURE

Research Update: A Pilot Radiogenomic Study of DIPG Reveals Distinct Subgroups With Unique Clinical Trajectories and Therapeutic Targets

This project was approved for funding by the DIPG/DMG Collaborative and The Cure Starts Now and here are the results: Quote from Dr. Rachid Drissi: “This is the first study to apply an approach combining magnetic resonance imaging (MRI) features and genomics in patients with DIPG in order to (1) investigate relationships between MRI characteristics at post-radiotherapy time points with tumor molecular profiles identified through extensive genome-wide sequencing analyses, and (2) further explore

In the Lab with Dr. Carl Koschmann: Therapeutic Reversal of Pre-natal Pontine ID1 Signaling in DIPG

Researcher at the University of Michigan Hospitals The Cure Starts Now recently sat down with Dr. Carl Koschmann to discuss his research grant for Therapeutic Reversal of Pre-natal Pontine ID1 Signaling in DIPG. What is the purpose of your research? “Our aim is to get sequencing from as many spots as we could separate from the pons, where the tumor is located, and, effectively, get as much information as we could about each spot, while trying to figure out how the spots were different and how w

The Cure Starts Now Teams Up With Over 200 Families for a Give-a-thon to Fight Cancer

“100 Families Strong” Virtual Give-a-Thon on November 20, 2020 Cincinnati, OH | November 16, 2020 — The Cure Starts Now announces that its annual “100 Families Strong” Give-a-Thon will take place this year on Giving First Day, November 20, 2020. The 2019 Give-a-Thon raised almost $300,000. More than 200 families from around the world are joining together for Giving First Day on November 20, 2020, to participate in The Cure Starts Now’s virtual “100 Families Strong” Give-a-Thon to raise money for

Corporate Giving Reaches New Level

COVID-19 has caused so many typical office traditions and practices to be put on hold or even canceled altogether.  With the holidays approaching, companies usually rely on the festive spirit to create comradery and team-building with such holiday favorites as white elephant exchanges, customer gift drop-offs, and company parties.  This year, those practices may not be possible.  But consider starting a new tradition.  Dedicate the amount of money typically spent on parties or customer gifts to

Re-irradiation Side Effects and Considerations

This article originally appeared on DIPG.org The Cure Starts Now sat down with Dr. Luke Pater, Associate Professor of Radiation Oncology at the University of Cincinnati Department of Radiation Oncology and Cincinnati Children’s Hospital, to discuss re-irradiation in terms of DIPG, DMG and medulloblastoma. Recently families facing progression of DIPG, DMG and Medulloblastoma have received recommendations to consider re-irradiation, can you explain what this involves? Re-irradiation for brain

Translating Clinical Trials

Keith Desserich, Chairman of the Board at The Cure Starts Now, explains clinical trials – what they mean for cancer patients and how they work. Clinical trials are set up in phases, all designed to focus on an idea. We call these preclinical, or even translational research trials. They are designed to conduct testing on cancer cells in a test tube or mouse modeling.  Ultimately you are trying to determine whether or not this idea, this concept, is actually going to work on cancer cells. From

Cancer Research Fundraiser Goes Global & Exceeds Expectations by 700% Despite COVID-19

The Cure Starts Now’s "The Great Relay for Research" Raised Over $175,000 for Homerun Cure™ Cancer Research Cincinnati, OH | October 1, 2020 — The Cure Starts Now’s first annual “The Great Relay for Research” raised $179,105 for Homerun Cure™ cancer research surpassing their original goal by over 700 percent. With the cancellation of nearly 120 crucial spring and summer fundraising events due to the ongoing COVID-19 pandemic, the cancer research grant funding cycle for The Cure Starts Now is in

Research Update: Integration of Multiple Platforms for the Analysis of Multifluorescent Marking Technology Applied to DIPG

In 2017 Dr. Mara Vinci of the Bambino Gesù Children’s Hospital proposed an innovative study into investigating the role of DIPG-derived exosomes in tumor growth and invasion. This project was approved for funding by the DIPG/DMG Collaborative and The Cure Starts Now and here are his results: Integration of Multiple Platforms for the Analysis of Multifluorescent Marking Technology Applied to Pediatric GBM and DIPG Abstract The intratumor heterogeneity represents one of the most difficult challeng

Cincinnati Children's Announces Naming of Brain Tumor Center

The following article first appeared on cincinnatichildrens.org: Brain Tumor Center to be named after foundation that helps fight pediatric brain cancers Cincinnati Children’s Hospital Medical Center and The Cure Starts Now Foundation have been working together for more than 12 years to find ways to cure pediatric cancers. To recognize the collaboration, Cincinnati Children’s is announcing the naming of The Cure Starts Now Foundation Brain Tumor Center as part of a multimillion-dollar donatio

Graeter's Annual Cones for the Cure Campaign Raises Over $1 Million

Cones For The Cure Fundraising Campaign Has Raised Over $1 Million For Homerun Cure™ Cancer Research Since It Began In 2009 Cincinnati, OH | September 11, 2020 — The Cure Starts Now, in partnership with Graeter’s, today announced that the Cones for the Cure campaign has raised over $1 million in funds for Homerun Cure™ cancer research since its inception in 2009. The Cure Starts Now and Graeter’s have teamed up for the past 11 years to raise funds for crucial cancer research through the Cones